These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Growth of bacteria in vitro in blood from patients with severe iron deficiency anemia and from patients with sickle cell anemia. Masawe AE; Msazumuhire H Am J Clin Pathol; 1973 May; 59(5):706-11. PubMed ID: 4702688 [No Abstract] [Full Text] [Related]
6. Iron status in white sickle cell disease patients. Russo-Mancuso G; Samperi P; Gangarossa S; Consalvo C; SchilirĂ² G Eur J Haematol; 1992 Apr; 48(4):232-3. PubMed ID: 1592104 [No Abstract] [Full Text] [Related]
7. [Iron status in 72 Congolese patients with sickle cell anemia]. Tshilolo L; Zita MN; Ngiyulu R; Kayembe Nzongola D Med Sante Trop; 2016; 26(1):83-7. PubMed ID: 26987842 [TBL] [Abstract][Full Text] [Related]
8. Serum protein and transferrin determinations to distinguish kwashiorkor from iron deficiency anaemia. Masawe AE; Rwabwogo-Atenyi J Arch Dis Child; 1973 Dec; 48(12):927-31. PubMed ID: 4128885 [No Abstract] [Full Text] [Related]
9. Immunity, transferrin, and survival in kwashiorkor. Reddy S; Adcock KJ; Adeshina H; Cooke AR; Akene J; McFAarlane H Br Med J; 1970 Oct; 4(5730):268-70. PubMed ID: 4097651 [TBL] [Abstract][Full Text] [Related]
10. Letter: Iron and resistance to infection. Braeman J Lancet; 1974 Sep; 2(7880):601. PubMed ID: 4140320 [No Abstract] [Full Text] [Related]
11. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients. Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137 [TBL] [Abstract][Full Text] [Related]
13. Serum copper, iron and iron binding capacity in kwashiorkor. EDOZIEN JC; UDEOZO IO J Trop Pediatr Afr Child Health; 1960 Sep; 6():60-4. PubMed ID: 13725747 [No Abstract] [Full Text] [Related]
14. Plasmodium falciparum malaria: its effects on some haematological parameters in normal and sickle cell Nigerian children. Ayatse JO; Ekanem EE Trop Med Parasitol; 1994 Sep; 45(3):219-22. PubMed ID: 7899791 [TBL] [Abstract][Full Text] [Related]
15. Anaemia in kwashiorkor. Reddy V; Srikantia SG Indian J Med Res; 1970 May; 58(5):645-50. PubMed ID: 5473264 [No Abstract] [Full Text] [Related]
16. Clinical trial of riboflavin in sickle cell disease. Ajayi OA; George BO; Ipadeola T East Afr Med J; 1993 Jul; 70(7):418-21. PubMed ID: 8293700 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulins, transferrin, caeruloplasmin and heterophile antibodies in kwashiorkor. McFarlane H; Reddy S; Cooke A; Longe O; Onabamiro MO; Houba JE Trop Geogr Med; 1970 Mar; 22(1):61-4. PubMed ID: 4190990 [No Abstract] [Full Text] [Related]
18. Values for copper, iron and iron-binding capacity in the serum in kwashiorkor. LAHEY ME; BEHAR M; VITERI F; SCRIMSHAW NS Pediatrics; 1958 Jul; 22(1, Part 1):72-9. PubMed ID: 13553607 [No Abstract] [Full Text] [Related]
19. Plasma free iron: a possible cause of oedema in kwashiorkor. Sive AA; Dempster WS; Malan H; Rosseau S; Heese HD Arch Dis Child; 1997 Jan; 76(1):54-6. PubMed ID: 9059163 [TBL] [Abstract][Full Text] [Related]